KEGG pathway analysis results exhibited that the 92 potential targets of Dingqing Tablet in AML treatment were mainly correlated with both PI3K-Akt and MAPK signaling pathways, of which AKT served as a core protein of the PI3K-Akt signaling pathway. This evidence concerns the gene AKT1 and acute myeloid leukemia.